The invention is a double-stranded oligoribonucleotide or a
physiologically compatible salt thereof, which is capable of inducing the
degradation of mRNA of one of more structures involved in inflammation or
irritation of the skin. The invention is also cosmetic or therapeutic
compositions comprising one or more such double-stranded
oligoribonucleotide and methods of treatment by use thereof.